De Bakshi D, Chen Y, Wuerzberger-Davis S, Ma M, Waters B, Li L
Life Sci Alliance. 2023; 6(3).
PMID: 36625202
PMC: 9748848.
DOI: 10.26508/lsa.202201636.
Bera A, Lewis S
Int J Mol Sci. 2020; 21(11).
PMID: 32517298
PMC: 7312463.
DOI: 10.3390/ijms21114075.
Takaya A, Yamamoto T, Tokoyoda K
Front Immunol. 2020; 10:3155.
PMID: 32038650
PMC: 6985548.
DOI: 10.3389/fimmu.2019.03155.
Manne C, Takaya A, Yamasaki Y, Mursell M, Hojyo S, Wu T
Proc Natl Acad Sci U S A. 2019; 116(15):7425-7430.
PMID: 30910977
PMC: 6462062.
DOI: 10.1073/pnas.1818242116.
Montuori N, Pesapane A, Giudice V, Serio B, Rossi F, De Paulis A
Transl Med UniSa. 2016; 15:8-14.
PMID: 27896222
PMC: 5120745.
A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
Jiang G, Zhang X, Zhang Y, Wang L, Fan C, Xu H
Tumour Biol. 2015; 36(10):7881-9.
PMID: 25953261
DOI: 10.1007/s13277-015-3500-5.
C6orf106 enhances NSCLC cell invasion by upregulating vimentin, and downregulating E-cadherin and P120ctn.
Zhang X, Miao Y, Yu X, Zhang Y, Jiang G, Liu Y
Tumour Biol. 2015; 36(8):5979-85.
PMID: 25736925
DOI: 10.1007/s13277-015-3274-9.
Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression.
Khan R, Gupta N, Kumar R, Sharma M, Kumar L, Sharma A
Clin Exp Metastasis. 2014; 31(5):585-93.
PMID: 24807734
DOI: 10.1007/s10585-014-9652-7.
Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
Chetty C, Khumalo T, Dias B, Reusch U, Knackmuss S, Little M
PLoS One. 2014; 9(5):e96268.
PMID: 24798101
PMC: 4010454.
DOI: 10.1371/journal.pone.0096268.
scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints.
Watson R, Broome T, Levings P, Rice B, Kay J, Smith A
Gene Ther. 2012; 20(6):670-7.
PMID: 23151520
PMC: 3577988.
DOI: 10.1038/gt.2012.81.
PDGF enhances IRES-mediated translation of Laminin B1 by cytoplasmic accumulation of La during epithelial to mesenchymal transition.
Petz M, Them N, Huber H, Mikulits W
Nucleic Acids Res. 2012; 40(19):9738-49.
PMID: 22904067
PMC: 3479205.
DOI: 10.1093/nar/gks760.
Green tea polyphenol sensing.
Tachibana H
Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(3):66-80.
PMID: 21422740
PMC: 3066547.
DOI: 10.2183/pjab.87.66.
37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells.
Poon S, Klausen C, Hammond G, Leung P
Mol Endocrinol. 2011; 25(2):327-38.
PMID: 21193558
PMC: 5417312.
DOI: 10.1210/me.2010-0334.
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.
Goudenege S, Lamarre Y, Dumont N, Rousseau J, Frenette J, Skuk D
Mol Ther. 2010; 18(12):2155-63.
PMID: 20683444
PMC: 2997583.
DOI: 10.1038/mt.2010.165.
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
Pennisi A, Li X, Ling W, Khan S, Gaddy D, Suva L
Br J Haematol. 2009; 145(6):775-87.
PMID: 19388929
PMC: 2748971.
DOI: 10.1111/j.1365-2141.2009.07696.x.
Extravasation and homing mechanisms in multiple myeloma.
Vande Broek I, Vanderkerken K, Van Camp B, Van Riet I
Clin Exp Metastasis. 2007; 25(4):325-34.
PMID: 17952614
DOI: 10.1007/s10585-007-9108-4.
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.
Shammas M, Neri P, Koley H, Batchu R, Bertheau R, Munshi V
Blood. 2006; 108(8):2804-10.
PMID: 16809610
PMC: 1895573.
DOI: 10.1182/blood-2006-05-022814.
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
Vande Broek I, Asosingh K, Vanderkerken K, Straetmans N, Van Camp B, Van Riet I
Br J Cancer. 2003; 88(6):855-62.
PMID: 12644822
PMC: 2377079.
DOI: 10.1038/sj.bjc.6600833.
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.
Asosingh K, Menu E, Van Valckenborgh E, Vande Broek I, Van Riet I, Van Camp B
Clin Exp Metastasis. 2002; 19(7):583-91.
PMID: 12498387
DOI: 10.1023/a:1020987830132.